Maya Guglin

@HoustonShockHSS @BurkhoffMd @CSWorkingGroup @JumeanMarwan @NirUrielMD @Nikhil15 Who agrees with me that in cardiogenic shock each subsequent SCAI stage should carry higher mortality? If yes -why SCAI B is higher than C? I called it the SCAI B mortality pardox- just presented at THT. All hypotheses are welcome!

Infarct size is not reduced in patients with anterior #STEMI without shock if they receive a combination of a trans-valvular micro-axial flow pump plus delayed #PCI versus PCI alone, results from the STEMI-Door to Unload trial show. #ACC26 on #CRTonline ow.ly/VIXa50YAX5j

@RyanTedfordMD @RahulArgula @kurt_prins @sese_denise @AndrewJSauer @yreddyhf @robmentz @MUSCCardFellows @ACCinTouch @hvanspall @VishalNRao Hope they will approve it now for HFpEF! Very interesting!

🔥Excited for the Phase 2 CADENCE trial results of sotatercept in Cpc-PH (due to HFpEF) as a Late-Breaking Clinical Trial at #ACC26! Topline data already released: met primary endpoint with significant PVR reduction. Huge shoutout to the incredible team behind this—promising step forward for this challenging group! ⭐️ @mardigomberg @jeanlucvachiery @MUSC_Cardiology @AlessiaUrbinati

@JumeanMarwan @HoustonShockHSS Congratulations, Marwan! What a meeting!

@HoustonShockHSS Loved the energy!!

I think all points are well taken. To me, the primary reason - they are not treated, because as soon as they are on any vasopressor or device, they become stage C. The question is - should we use the SCAI classes as stages - and then mortality is expected to increase - or as phenotypes, and then mortality does not have to get progressively worse.

@MGuglin @HoustonShockHSS @BurkhoffMd @CSWorkingGroup @JumeanMarwan @NirUrielMD @Nikhil15 it’s that B can be a contaminated category: under-recognized hypoperfusion, variable timing of staging, and support-driven labels that distort the natural severity→mortality gradient? jacc.org/doi/10.1016/j.…

@HoustonShockHSS @BurkhoffMd @CSWorkingGroup @JumeanMarwan @NirUrielMD @Nikhil15 Who agrees with me that in cardiogenic shock each subsequent SCAI stage should carry higher mortality? If yes -why SCAI B is higher than C? I called it the SCAI B mortality pardox- just presented at THT. All hypotheses are welcome!

Out of hospital cardiac arrest in cardiogenic shock equals SCAI stage E, right? Perhaps… sharing my thoughts at THT.@CSWorkingGroup @BurkhoffMd @NirUrielMD @JumeanMarwan @Nikhil15 @MarkBelkinMD

In-hospital and out-of hospital cardiac arrest in cardiogenic shock- same or different? Proud to present at THT. @CSWorkingGroup @BurkhoffMd @JumeanMarwan @MarkBelkinMD @Nikhil15

HF2 is the group working on remote hemodynamic monitoring. Dr. Thomas Heywood, the founder and the soul of the group, presenting at THT.

THT is the best HF meeting! The Barnabas/Rutgers team.

Rutgers students and residents presenting scientific abstracts at THT! Proud of Paul Kaddissi and Sakeeb Khan!

Not all ICDs in patients with LVAD are futile! We recorded immediate drop in pulmonary pressures and increase in CVP in an LVAD patient who went into ventricular fibrillation, with immediate recovery post defibrillation. Check out our case report! digitalcommons.library.tmc.edu/cgi/viewconten…

The #CSWG was honored to recognize @BurkhoffMd with a Lifetime Achievement Award for his contributions to cardiovascular medicine, heart failure, cardiogenic shock, hemodynamics, and for his humility and mentorship. Thank you Marty Leon for the Keynote! @crfheart @hopkinsheart

This statement provides guidance on the role of static, provocative, and serial assessments of invasive hemodynamics in phenotyping and management of patients with heart failure, pulmonary hypertension, left ventricular assist support devices, and cardiogenic shock. Further research is needed to better understand how to individualize care in response to dynamic testing. ✍🏼 @MarkBelkinMD @FudimMarat @cla_baratto @JonGrinsteinMD @IanBHollis @rachkataria @GLewisCardiol @MakLab_ @RyanTedfordMD @JTThibs @JP_HFpEF

Magnificent Carol of the Bells!!! youtube.com/watch?v=ivVPqw…

High-Granularity Machine Learning Prediction of Acute Brain Injury in Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation ASAIO Journal 71(12):p 1013-1022, December 2025. | DOI: 10.1097/MAT.0000000000002449 ow.ly/VHnq50XMGco #ASAIO

Congratulations to our Heart Failure fellow Marcos Molina who mached to the Cardiology fellowship at Rutgers! And yes, we are looking for applicants to our non-ACGME accredited Advanced HF fellowship. If interested, please send you CV to maya.guglin@rutgers.edu. We'll teach you how to care for patients with HF, cardiogenic shock, post-LVAD, and heart transplant. We are in New Brunswick, NJ.

@MGuglin 💯% agree Dr Guilin!

@MGuglin Agree!

@MGuglin @RyanTedfordMD 💯 endorse this!

Who agrees with me? There is a dire shortage of doctors signing up to heart failure fellowships with >60% programs unfilled. I propose the following: - allow the entry into HF training to general internists—including those who did not match to cardiology - if they then proceed to cardiology fellowship, allow them to sit for HF Boards after they are Board certified in Cardiology - If they remain internists with HF training, create an alternative certificate for them. This would yield immediate benefits: - all available fellowship slots would be filled with eager and capable trainees - teaching faculty will be teaching again - the market will be saturated with HF doctors Read my whole piece pubmed.ncbi.nlm.nih.gov/41238042/ @HFSA @JACCJournals @nikhilna @NirUrielMD @Aheartdoc @AHAScience @EMDeFilippisMD @DmitryAbramovMD @EiranGorodeski